This page includes the latest FDA filings for Titan Pharmaceuticals Inc. Currently, you will find the latest 100 filings for Premarket Notifications, Premarket Applications, De Novo Applications, and GUDID registrations.
| USA | NASDAQ | TTNP | DUNS 807182720 |
Device Company | Device | Date |
|---|---|---|
| Titan Pharmaceuticals, Inc. | Prescription Medication | 2021-03-19 |
| Titan Pharmaceuticals, Inc. | Prescription Medication | 2020-11-04 |
| Titan Pharmaceuticals, Inc. | Prescription Medication | 2020-07-21 |
| Titan Pharmaceuticals, Inc. | Prescription Medication | 2019-11-28 |
| Titan Pharmaceuticals, Inc. | Prescription Medication | 2019-10-24 |
| Titan Pharmaceuticals, Inc. | Probuphine | 2016-06-09 |
| NCAGE Code | 47F74 | TITAN PHARMACEUTICALS, INC. |
| CAGE Code | 47F74 | TITAN PHARMACEUTICALS, INC. |
| S.A.M. Registration | 47F74 [807182720] | TITAN PHARMACEUTICALS, INC. |
| SEC | 0000910267 | TITAN PHARMACEUTICALS INC of DELAWARE |